Introduction::The incidence of Breast Cancer (BC), a prevalent malignancy
in women, has gone up recently, although the molecular pathways underlying the carcinogenesis
of BC are still unknown. Long non-coding RNAs (lncRNAs) have become
important tumor progression regulators.
Method::The present study has revealed increased expression of LINC00651 in BC tissues
through a thorough investigation of whole-transcriptome resequencing on matched
BC and normal tissues from 8 patients. It is yet unknown precisely as to what biological
function LINC00651 serves in BC.
To obtain further insight, 39 matched pairs of breast tumors and normal tissues underwent
Real-time quantitative Polymerase Chain Reaction (RT-qPCR) for validation. The
validated cohort's clinicopathologic characteristics were then carefully examined. Following
short interfering RNA transfection, proliferation, colony formation, migration, invasion,
and examination of phenotypes associated with the Epithelial-mesenchymal
Transition (EMT) were conducted in BC cell lines (MDA-MB-231 and BT-549).
Results::Our findings have confirmed that LINC00651 plays a role in augmenting BC
cell lines' proliferation, migration, and invasion. Consequently, LINC00651 can be considered
a potential new therapeutic target for BC treatment.
Conclusion::As breast cancer remains a significant health concern, understanding its
molecular underpinnings is crucial for developing effective treatments. The identification
of LINC00651 as a promoter of BC cell growth and metastasis has suggested that it
could be a promising target for future therapeutic interventions, potentially offering new
avenues for improved patient outcomes.